CAM
NBP

CIF Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

CIF Asset Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2.37M Hold
32,649
– – 2.78% 7
2021
Q2 		$2.74M Hold
32,649
– – 2.62% 7
2021
Q1 		$1.58M Buy
+32,649
New +$1.77M 3.22% 6

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

CIF Asset Management's NBP Position: Q3 2021 in Review

CIF Asset Management held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q3 2021 at 32,649 shares worth $2.37M. The position accounts for 2.78% of the portfolio, ranked #7.

CIF Asset Management first reported a position in NBP in Q1 2021 and has held it in 3 quarters since. The position peaked at $2.74M in Q2 2021. 144 funds tracked by Wall St. Rank hold NBP as of Q3 2021.

  • CIF Asset Management held 32,649 shares of NovaBridge Biosciences American Depositary Shares worth $2.37M as of Q3 2021.
  • CIF Asset Management left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q3 2021.
  • NovaBridge Biosciences American Depositary Shares made up 2.78% of CIF Asset Management's portfolio in Q3 2021, its #7 holding.
  • CIF Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and has held it in 3 quarters since.
  • CIF Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $2.74M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2021.

Based on CIF Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.